^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EGFR G719A + EGFR L833V

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
over2years
Effective treatment with icotinib in advanced lung adenocarcinoma harboring rare EGFR mutation G719A/L833V: A case report. (PubMed, Medicine (Baltimore))
This is the first report of the icotinib treatment achieving long-lasting and stable disease control in an NSCLC patient with EGFR G719A/L833V mutation. Icotinib could be a first-line treatment option in NSCLC patients harboring EGFR G719A/L833V mutation.
Journal
|
EGFR (Epidermal growth factor receptor)
|
EGFR mutation • EGFR G719A • EGFR G719A + EGFR L833V • EGFR L833V
|
Conmana (icotinib)